These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 11087767)
41. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial. Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684 [TBL] [Abstract][Full Text] [Related]
42. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240 [TBL] [Abstract][Full Text] [Related]
43. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. Lemke MR J Clin Psychiatry; 1995 Aug; 56(8):354-7. PubMed ID: 7635851 [TBL] [Abstract][Full Text] [Related]
44. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Kwentus J; Riesenberg RA; Marandi M; Manning RA; Allen MH; Fishman RS; Spyker DA; Kehne JH; Cassella JV Bipolar Disord; 2012 Feb; 14(1):31-40. PubMed ID: 22329470 [TBL] [Abstract][Full Text] [Related]
47. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I; JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594 [TBL] [Abstract][Full Text] [Related]
48. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder. Citrome L Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343 [TBL] [Abstract][Full Text] [Related]
49. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454 [TBL] [Abstract][Full Text] [Related]
51. Combined treatment with haloperidol and trazodone in patients with tic disorders. Saccomani L; Rizzo P; Nobili L J Child Adolesc Psychopharmacol; 2000; 10(4):307-10. PubMed ID: 11191691 [TBL] [Abstract][Full Text] [Related]
52. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study. Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial. Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778 [TBL] [Abstract][Full Text] [Related]
54. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. Kitamura Y; Kudo Y; Imamura T No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516 [TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Schneider LS; Frangakis C; Drye LT; Devanand DP; Marano CM; Mintzer J; Mulsant BH; Munro CA; Newell JA; Pawluczyk S; Pelton G; Pollock BG; Porsteinsson AP; Rabins PV; Rein L; Rosenberg PB; Shade D; Weintraub D; Yesavage J; Lyketsos CG; Am J Psychiatry; 2016 May; 173(5):465-72. PubMed ID: 26771737 [TBL] [Abstract][Full Text] [Related]